Literature DB >> 9722823

Fifteen years of research on preventing HIV infection among injecting drug users: what we have learned, what we have not learned, what we have done, what we have not done.

D C Des Jarlais1, S R Friedman.   

Abstract

OBJECTIVE: Acquired immunodeficiency syndrome (AIDS) was formally identified among injecting drug users (IDUs) in 1981, and research on preventing human immunodeficiency virus (HIV) infection among drug injectors began shortly thereafter. At the time this research was begun, there was a general assumption that drug user (who were called drug abusers at that time) were too self-destructive and their behavior too chaotic for them to change their behavior to avoid infection with HIV. This chapter reviews the history of research on implementation of programs for prevention of HIV infection among IDUs.
METHODS: Reviews of both research and program implementation research were conducted. Consultative discussions of issues and findings were conducted with researcher in the United States and other countries.
RESULTS: An extremely large amount of useful information has accumulated during the pat 15 years. We now know that the great majority of IDUs will change their injecting behavior in response to the threat of AIDS and that these behavior changes are effective in reducing HIV transmission among drug injectors. Additional insight is needed regarding the apparent insufficiency of some prevention programs to control HIV, the transmission dynamics of rapid HIV spread, and the persistence of moderate to high incidence of HIV infection in high seroprevalence populations. Despite the current research knowledge base, implementation of effective prevention programs in may countries is nonexistent to incomplete.
CONCLUSIONS: The most important barrier to reducing HIV transmission among drug injectors is not a lack of knowledge but the failure to implement effective prevention programs in may parts of the world.

Entities:  

Mesh:

Year:  1998        PMID: 9722823      PMCID: PMC1307740     

Source DB:  PubMed          Journal:  Public Health Rep        ISSN: 0033-3549            Impact factor:   2.792


  19 in total

1.  Needle exchange is not enough: lessons from the Vancouver injecting drug use study.

Authors:  S A Strathdee; D M Patrick; S L Currie; P G Cornelisse; M L Rekart; J S Montaner; M T Schechter; M V O'Shaughnessy
Journal:  AIDS       Date:  1997-07       Impact factor: 4.177

2.  International epidemiology of HIV and AIDS among injecting drug users.

Authors:  D C Des Jarlais; S R Friedman; K Choopanya; S Vanichseni; T P Ward
Journal:  AIDS       Date:  1992-10       Impact factor: 4.177

3.  Intravenous drug users--a new high-risk group for HIV infection in India.

Authors:  T N Naik; S Sarkar; H L Singh; S C Bhunia; Y I Singh; P K Singh; S C Pal
Journal:  AIDS       Date:  1991-01       Impact factor: 4.177

Review 4.  HIV among drug injectors: the epidemic and the response.

Authors:  S R Friedman; D C Des Jarlais
Journal:  AIDS Care       Date:  1991

5.  Epidemic of AIDS related virus (HTLV-III/LAV) infection among intravenous drug abusers.

Authors:  J R Robertson; A B Bucknall; P D Welsby; J J Roberts; J M Inglis; J F Peutherer; R P Brettle
Journal:  Br Med J (Clin Res Ed)       Date:  1986-02-22

6.  AIDS and self-organization among intravenous drug users.

Authors:  S R Friedman; D C Des Jarlais; J L Sotheran; J Garber; H Cohen; D Smith
Journal:  Int J Addict       Date:  1987-03

7.  HIV-1 infection among intravenous drug users in Manhattan, New York City, from 1977 through 1987.

Authors:  D C Des Jarlais; S R Friedman; D M Novick; J L Sotheran; P Thomas; S R Yancovitz; D Mildvan; J Weber; M J Kreek; R Maslansky
Journal:  JAMA       Date:  1989-02-17       Impact factor: 56.272

Review 8.  The first and second decades of AIDS among injecting drug users.

Authors:  D C Des Jarlais
Journal:  Br J Addict       Date:  1992-03

9.  The protective effect of AIDS-related behavioral change among injection drug users: a cross-national study. WHO Multi-Centre Study of AIDS and Injecting Drug Use.

Authors:  D C Des Jarlais; P Friedmann; H Hagan; S R Friedman
Journal:  Am J Public Health       Date:  1996-12       Impact factor: 9.308

10.  The harm reduction approach and risk factors for human immunodeficiency virus (HIV) seroconversion in injecting drug users, Amsterdam.

Authors:  E J van Ameijden; J A van den Hoek; H J van Haastrecht; R A Coutinho
Journal:  Am J Epidemiol       Date:  1992-07-15       Impact factor: 4.897

View more
  20 in total

1.  The social geography of AIDS and hepatitis risk: qualitative approaches for assessing local differences in sterile-syringe access among injection drug users.

Authors:  M Singer; T Stopka; C Siano; K Springer; G Barton; K Khoshnood; A Gorry de Puga; R Heimer
Journal:  Am J Public Health       Date:  2000-07       Impact factor: 9.308

2.  The Changing Epidemic of HIV.

Authors: 
Journal:  Curr Infect Dis Rep       Date:  2000-10       Impact factor: 3.725

3.  Displacement of Canada's largest public illicit drug market in response to a police crackdown.

Authors:  Evan Wood; Patricia M Spittal; Will Small; Thomas Kerr; Kathy Li; Robert S Hogg; Mark W Tyndall; Julio S G Montaner; Martin T Schechter
Journal:  CMAJ       Date:  2004-05-11       Impact factor: 8.262

4.  Social stability and health: exploring multidimensional social disadvantage.

Authors:  Danielle German; Carl A Latkin
Journal:  J Urban Health       Date:  2012-02       Impact factor: 3.671

5.  Phenomenologies of the akratic self: masculinity, regrets, and HIV among men on methadone.

Authors:  Jorge Fontdevila
Journal:  J Urban Health       Date:  2006-07       Impact factor: 3.671

6.  A social network profile and HIV risk among men on methadone: do social networks matter?

Authors:  Nabila El-Bassel; Louisa Gilbert; Elwin Wu; Mingway Chang
Journal:  J Urban Health       Date:  2006-07       Impact factor: 3.671

7.  Changes in HIV and AIDS in the United States: Entering the Third Decade.

Authors:  Scott Kellerman; Elin Begley; Brian Boyett; Hollie Clark; Jeff Schulden
Journal:  Curr Infect Dis Rep       Date:  2005-03       Impact factor: 3.725

8.  What's community got to do with it? Implementation models of syringe exchange programs.

Authors:  Moher Downing; Thomas H Riess; Karen Vernon; Nina Mulia; Marilyn Hollinquest; Courtney McKnight; Don C Des Jarlais; Brian R Edlin
Journal:  AIDS Educ Prev       Date:  2005-02

Review 9.  Changes in HIV and AIDS in the United States: entering the third decade.

Authors:  Scott Kellerman; Elin Begley; Brian Boyett; Hollie Clark; Jeff Schulden
Journal:  Curr HIV/AIDS Rep       Date:  2004-12       Impact factor: 5.071

10.  Drugscapes and the role of place and space in injection drug use-related HIV risk environments.

Authors:  Barbara Tempalski; Hilary McQuie
Journal:  Int J Drug Policy       Date:  2008-06-12
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.